Challenges and potential for RNA nanoparticles (RNPs).
J Biomed Nanotechnol
; 5(1): 36-44, 2009 Feb.
Article
em En
| MEDLINE
| ID: mdl-20055104
ABSTRACT
The current research of our group focuses on delivery of oligonucleotides and gene vaccines targeted against infectious disease and cancer. Recently we reported a strategy for associating DNA to gold via protamine delivery enhancing material which here we suggest might be applicable to RNA and to other nanoparticles. An important new modality for such RNA based nanoparticles (RNPs) is the myriad of genes now known to undergo alternative splicing. Here we will review some important issues for the binding, stabilization and delivery of RNA, particularly splice-site switching oligomers (SSOs) via these RNPs in order to achieve selective molecular therapeutic effects and unlock their potential as chemotherapeutic agents.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
RNA
/
Portadores de Fármacos
/
Transfecção
/
Composição de Medicamentos
/
Nanomedicina
/
Nanopartículas
Idioma:
En
Revista:
J Biomed Nanotechnol
Ano de publicação:
2009
Tipo de documento:
Article
País de afiliação:
Estados Unidos